These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6187031)

  • 1. Antiallergic compounds.
    Davies RJ; Moodley I
    Pharmacol Ther; 1982; 17(3):279-97. PubMed ID: 6187031
    [No Abstract]   [Full Text] [Related]  

  • 2. The inhibitory effect of ketotifen on in vitro histamine release in allergic patients.
    Oehling A; Ona J; Wierna G; Sanz ML; Castillo J
    Allergol Immunopathol (Madr); 1985; 13(6):475-85. PubMed ID: 2421563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of various antiallergic agents using a new method for inducing systemic anaphylaxis in the rat.
    Ufkes JG; Ottenhof M
    J Pharmacol Methods; 1984 Jun; 11(3):219-26. PubMed ID: 6429452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological influence of antiallergic medication on in vivo allergen testing.
    Pipkorn U
    Allergy; 1988 Feb; 43(2):81-6. PubMed ID: 2896467
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells.
    Okayama Y; Church MK
    Int Arch Allergy Immunol; 1992; 97(3):216-25. PubMed ID: 1375203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of non-steroidal antiallergic eyedrops on the complement-mediated histamine release from human cells.
    Goldschmidt P; Couturier C; Haeffner-Cavaillon N; Kazatchkine M; Herman D
    Ocul Immunol Inflamm; 1997 Mar; 5(1):11-7. PubMed ID: 9145688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-course of the histamine release from human peripheral blood monocytes and the influence of ketotifen and disodium cromoglycate (DSCG).
    Zwadlo-Klarwasser G; Braam U; Jungbluth C; Schmutzler W
    Inflamm Res; 1995 Apr; 44 Suppl 1():S18-9. PubMed ID: 8520980
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiallergic activity of tiaramide (RHC 2592-A).
    Khandwala A; Coutts S; Weinryb I
    Int Arch Allergy Appl Immunol; 1982; 69(2):159-68. PubMed ID: 6179887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative antiallergic and anti-inflammatory action of F1865, mepyramine maleate, desonide and disodium cromoglycate after cutaneous administration].
    Tarayre JP; Aliaga M; Villanova G; Barbara M; Bru M; Caillol V; Lauressergues H
    J Pharmacol; 1984; 15(1):37-51. PubMed ID: 6425568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of sulfur dioxide-induced airways hyperresponsiveness in the conscious dog.
    Lewis AJ; Kirchner T
    Int Arch Allergy Appl Immunol; 1984; 75(2):188-90. PubMed ID: 6432705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of histamine release from human blood monocytes, lymphocytes, adenoidal and skin mast cells.
    Schmutzler W; Bolsmann K; Zwadlo-Klarwasser G
    Int Arch Allergy Immunol; 1995; 107(1-3):194-6. PubMed ID: 7542070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1974; 7(3):164-282. PubMed ID: 4212341
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of allergic reactions by cromoglycate and by a new anti-allergy drug U-42,585E. I. Activity in rats.
    Johnson HG; VanHout CA; Wright JB
    Int Arch Allergy Appl Immunol; 1978; 56(5):416-23. PubMed ID: 75851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acrylamide derivatives as antiallergic agents. 2. Synthesis and structure-activity relationships of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(3-pyridyl)acryl amides.
    Nishikawa Y; Shindo T; Ishii K; Nakamura H; Kon T; Uno H
    J Med Chem; 1989 Mar; 32(3):583-93. PubMed ID: 2465410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of Wy-41,195, an orally effective antiallergic drug in animal models.
    Lewis AJ; Carlson RP; Forster TJ; Chang J; Hand JM; Undem BJ; Buckner CK; Tio C; Sisenwine SF; Daniel WC
    Agents Actions; 1986 Jun; 18(3-4):306-12. PubMed ID: 2428218
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of antianaphylactic agents on substance-P induced histamine release from rat peritoneal mast cells.
    Hachisuka H; Nomura H; Sakamoto F; Mori O; Okubo K; Sasai Y
    Arch Dermatol Res; 1988; 280(3):158-62. PubMed ID: 2454082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. II. Comparison of RHC 3164 with disodium cromoglycate.
    Khandwala A; Dally-Meade V; Jariwala N; Huang F
    Int Arch Allergy Appl Immunol; 1984; 73(1):65-70. PubMed ID: 6198288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell mediators in asthma. Clinical uses of the inhibitors.
    Seropian E; Filip V; Iamandescu I
    Allergol Immunopathol (Madr); 1981; Suppl 9():23-7. PubMed ID: 6187197
    [No Abstract]   [Full Text] [Related]  

  • 19. Mast cell stabilizing agents in nasal allergy.
    van Cauwenberge PB
    Rhinology; 1984 Mar; 22(1):21-6. PubMed ID: 6328630
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacologic profile of wy-41,195, a new orally effective antiallergic agent.
    Carlson RP; Dervinis A; DiLuigi JM; Capetola RJ; Rosenthale ME; Lewis AJ
    Arzneimittelforschung; 1982; 32(12):1546-53. PubMed ID: 6186261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.